Enact Holdings Inc. Common Stock (ACT)

FairStock Score: 77/100 — HIGH CONVICTION

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Enact as a specialist insurer, not a bank. It writes private mortgage insurance for U.S. lenders, and at the close on 2026-10-13 it sells for $44.93 with a $6.2B market cap. The filed numbers show continuity: fiscal Q2 2026 revenue was $317.3M and diluted EPS was $1.25; fiscal Q1 2026 revenue was $312.1M with EPS $1.18; fiscal Q3 2025 revenue was $311.5M with EPS $1.10; and fiscal Q2 2025 revenue was $304.9M with EPS $1.11. For full years, FY2025 had revenue of $1.2B, net income of $674.2M and diluted EPS of $4.52; FY2024 net income was $688.1M and EPS $4.37; FY2023 net income was $665.5M and EPS $4.11. So earnings have been fairly consistent, though FY2025 net income slipped from FY2024. FairStock calculates a P/E of 9.48 and P/B of 1.15, with ROE of 12.87%, D/E of 0.14 and a 1.98% dividend yield. That is not demanding, but it is not a giveaway either. The FairStock Lynch category is Slow Grower — Shrinking: profit -0.1% a year over five years, revenue 4.8%. The moat is modest: lender relationships and scale matter, but PMI is competitive and tied to housing credit. Missing CET1, NIM and combined ratio prevent a full capital and underwriting review. I would call it a fair, cyclical financial, not a bargain.

In plain English: Enact sells insurance that protects mortgage lenders if homeowners default. The business is profitable and carries little debt, but it grows slowly and depends on the housing market staying healthy. At $44.93 on 2026-10-13, the stock looks moderately priced compared with its profits and net assets, not clearly cheap or expensive.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer